These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26059516)

  • 61. Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.
    He Z; Kisla D; Zhang L; Yuan C; Green-Church KB; Yousef AE
    Appl Environ Microbiol; 2007 Jan; 73(1):168-78. PubMed ID: 17071789
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Polymyxin B biosynthesis and tricarboxylic acid cycle enzymatic activity].
    Nefelova MV; Novikova GA; Ermakova GN; Egorov NS
    Antibiotiki; 1978 Aug; 23(8):682-6. PubMed ID: 210709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation of two new polymyxin group antibiotics. (Studies on antibiotics from the genus Bacillus. XX).
    Shoji J; Hinoo H; Wakisaka Y; Koizumi K; Mayama M; Matsuura S
    J Antibiot (Tokyo); 1977 Dec; 30(12):1029-34. PubMed ID: 202582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Decreased particulate NADH oxidase activity in Bacillus subtilis spores after polymyxin B treatment.
    Tochikubo K; Yasuda Y; Kozuka S
    J Gen Microbiol; 1986 Feb; 132(2):277-87. PubMed ID: 3011961
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Simplified Method for Gene Knockout and Direct Screening of Recombinant Clones for Application in Paenibacillus polymyxa.
    Kim SB; Timmusk S
    PLoS One; 2013; 8(6):e68092. PubMed ID: 23826364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression system for recombinant human growth hormone production from Bacillus subtilis.
    Ozdamar TH; Sentürk B; Yilmaz OD; Calik G; Celik E; Calik P
    Biotechnol Prog; 2009; 25(1):75-84. PubMed ID: 19224557
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Engineered short branched-chain acyl-CoA synthesis in E. coli and acylation of chloramphenicol to branched-chain derivatives.
    Bi H; Bai Y; Cai T; Zhuang Y; Liang X; Zhang X; Liu T; Ma Y
    Appl Microbiol Biotechnol; 2013 Dec; 97(24):10339-48. PubMed ID: 24100682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimization of amorphadiene synthesis in bacillus subtilis via transcriptional, translational, and media modulation.
    Zhou K; Zou R; Zhang C; Stephanopoulos G; Too HP
    Biotechnol Bioeng; 2013 Sep; 110(9):2556-61. PubMed ID: 23483530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Study of the vitamin nutrition of Bac. polymyxa Ross, a polymyxin M producer].
    Kachan VI
    Mikrobiol Zh; 1968; 30(6):510-4. PubMed ID: 4308968
    [No Abstract]   [Full Text] [Related]  

  • 70. [Polymyxin M biosynthesis by Bacillus polymyxa Ross depending on the source of ammonium nitrogen and its concentration in the medium].
    Pavliuk IuV; Bogats'kii MO; Preobrazhens'kii LM; Evseeva trm
    Mikrobiol Zh; 1975; 37(5):590-3. PubMed ID: 176560
    [No Abstract]   [Full Text] [Related]  

  • 71. [Isolation and characterization of mutants of Bacillus subtilis resistant to polymyxin].
    Cacco G
    Boll Soc Ital Biol Sper; 1975 Feb; 51(3):99-105. PubMed ID: 167795
    [No Abstract]   [Full Text] [Related]  

  • 72. Engineered Bacillus subtilis 168 produces L-malate by heterologous biosynthesis pathway construction and lactate dehydrogenase deletion.
    Mu L; Wen J
    World J Microbiol Biotechnol; 2013 Jan; 29(1):33-41. PubMed ID: 22914898
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and functional analysis of the fusaricidin biosynthetic gene of Paenibacillus polymyxa E681.
    Choi SK; Park SY; Kim R; Lee CH; Kim JF; Park SH
    Biochem Biophys Res Commun; 2008 Jan; 365(1):89-95. PubMed ID: 17980146
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Incorporation of C14-L-threonine and C14-L-leucine into the polymyxin M molecule].
    Nefelova MV; Pattakhov AA; Silaev AB
    Antibiotiki; 1971 Jun; 16(6):499-504. PubMed ID: 4329597
    [No Abstract]   [Full Text] [Related]  

  • 75. Mode of action of polymyxin B: physiological studies with Bacillus subtilis-resistant mutant.
    Galizzi A; Cacco G; Siccardi AG; Mazza G
    Antimicrob Agents Chemother; 1975 Sep; 8(3):366-9. PubMed ID: 170857
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic engineering to enhance heterologous production of hyaluronic acid in Bacillus subtilis.
    Westbrook AW; Ren X; Oh J; Moo-Young M; Chou CP
    Metab Eng; 2018 May; 47():401-413. PubMed ID: 29698777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Module and individual domain deletions of NRPS to produce plipastatin derivatives in Bacillus subtilis.
    Gao L; Guo J; Fan Y; Ma Z; Lu Z; Zhang C; Zhao H; Bie X
    Microb Cell Fact; 2018 May; 17(1):84. PubMed ID: 29855381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Construction of recombinant Bacillus subtilis for production of polyhydroxyalkanoates.
    Wang Y; Ruan L; Lo WH; Chua H; Yu HF
    Appl Biochem Biotechnol; 2006; 129-132():1015-22. PubMed ID: 16915708
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Production of D-arabitol by a metabolic engineered strain of Bacillus subtilis.
    Povelainen M; Miasnikov AN
    Biotechnol J; 2006 Feb; 1(2):214-9. PubMed ID: 16892251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of amino acids on the growth of Bacillus polymyxa var. Ross and on the formation of polymyxin M].
    Cherkesova GV; Nefelova MV; Silaev AB
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1971; 1(85):88-91. PubMed ID: 4341059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.